Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.
The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.
Akasa Air Mumbai To Kuwait Flight Delay Sparks Chaos At Airport Terminal, Passengers Allege Poor Communication - VIDEO
Mumbai: Jogeshwari School’s Sudden Closure Plan Sparks Panic Among Parents, MNS Steps In
AI To Add $550 Billion To India's Economy By 2035: PwC Flagship Study Unveils 3A2I Framework At Davos 2026
Dream Sports MSSA Inter-School Football Tournament: Ascend International Win U-10 Division 2 Title, Smt RSB AVM Take Third Place
